Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Overall Adverse Event Rates Dose Group Any Adverse Event (%) GI Adverse Events (%) Discontinuation Due to AE (%) Placebo 72.1% 32.6% 0% 1 mg 88.6% 48.6% 2.9% 4 mg (escalated) 88.6% 60.0% 5.7% 4 mg (single dose) 90.9% 63.6% 6.1% 8 mg (escalated) 87.5% 57.5% 5.0% 8 mg (single dose) 88.6% 62.9% 5.7% 12 mg (escalated) 97.2% 66.7% 8.3% Source: Jastreboff AM, Kaplan LM, Fras JP, et al
Starter concentration
Pinnacle Peptides supplies Sermorelin at 5mg per vial, synthesised via solid-phase methodology and verified at 99%+ purity by HPLC and Mass Spectrometry
doi: 10.1038/npp.2009.75 18 BremnerJ
The collaboration between Zealand and BI dates back to 2011, when the two parties agreed to develop drug candidates for the treatment of type 2 diabetes and obesity
